期刊文献+

曲马多联合顺铂对人肺腺癌细胞A549侵袭和迁移的影响 被引量:7

The effects of tramadol combined with cisplatin on invasionon and migration of human lung adenocarcinoma cell A549
下载PDF
导出
摘要 目的评价曲马多联合顺铂对人肺腺癌细胞A549侵袭和迁移的影响。方法人肺腺癌细胞A549接种于培养板培养24h,随机分为五组:对照组(CON组),顺铂组(CIS组),3μg/ml曲马多+顺铂组(TT1组),30μg/ml曲马多+顺铂组(TT2组)和300μg/ml曲马多+顺铂组(TT3组),顺铂浓度均为4μg/ml。各组分别加入药物孵育48h后即刻,采用Transwell法检测细胞侵袭能力,细胞划痕实验检测细胞迁移能力,Western blot法检测基质金属蛋白酶-2(MMP-2)、MMP-9、Ezrin蛋白和Fascin蛋白的表达。结果与CON组比较,其余四组肿瘤细胞侵袭和迁移能力明显降低(P<0.05),TT3组MMP-2、MMP-9、Ezrin和Fascin蛋白表达明显下调(P<0.05)。与CIS组比较,TT1组、TT2组和TT3组肿瘤细胞侵袭和迁移能力明显降低(P<0.05),TT3组MMP-2、MMP-9、Ezrin和Fascin蛋白表达明显下调(P<0.05)。结论曲马多剂量依赖性地增强顺铂对人肺腺癌细胞A549的侵袭和迁移的抑制作用,MMP-2、MMP-9、Ezrin和Fascin表达下调可能是其机制之一。 Objective To investigate the effect of tramadol combined with cisplatin on invasion- on and migration of human lung adenocarcinoma cell A549. Methods Human lung adenocarcinoma A549 cells were inoculated on cultured for 24 h, then were randomly divided into 5 groups: control group(group CON), cisplatin group(group CIS), tramadol 3 /μg/ml+eisplatin group(group TT1), tramadol 30/μg/mlq-cisplatin group(group TT2), tramadol 300/zg/ml+cisplatin group(group TT3). Concentration of cisplatin was 4 /μg/ml. Each group were medicated immediately after 48 h incuba- tion, invasion detection cells by Transwell assay, cell scratch assay cell migration ability, Western- blot detection of matrix metalloproteinase-2 (MMP-2), the expression of MMP-9, Ezrin protein and Fascin protein. Results Compared with group CON, group CIS and tramadol cmbined with cisplatin group redueced tumor cell invasion and migration ability, group TT3 and CIS up-regulated MMP-2, MMP-9, Ezrin and Fascin expression (P〈0.05). Compared with group CIS, tramadol combined with cisplatin group reduced tumor cell migration and invasion. Group TT3 down-regulated MMP-2, MMP-9, Ezrin and Fascin expression (P〈0.05). Conclusion Tramadol could dose-dependently en- hance cisplatin on invasion and migration of human lung adenocarcinoma cell A549, down-regulation MMP-2, MMP-9, Ezrin and Fascin expression is one of its possible mechanisms.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2015年第4期391-394,共4页 Journal of Clinical Anesthesiology
关键词 曲马多 顺铂 肿瘤侵袭 迁移 Tramadoll Cisplatin Tumor Invasion Migration
  • 相关文献

参考文献10

  • 1夏明,童建华,高炟鹏,徐建国.吗啡联合顺铂对人肺腺癌细胞 A549侵袭和迁移的影响[J].临床麻醉学杂志,2014,30(12):1227-1230. 被引量:7
  • 2Choi BE), Jeong SJ', Wang G, et al. Secretory leukocyte pro- tease inhibitor is associated with MMP-2 and MMP-9 to pro- mote migration and invasion in SNU638 gastric cancer cells. Int J Mol Med,2011,28(4) :527-534.
  • 3Nalla N, Berg E, Uhlin-Hasen L, et al. Interaction of pro- matrix metalloproteinases-9/proteoglycan heteromer with ge- lation and collagen. J Biol Chem, 2008, 283 (20): 13652-13665.
  • 4Perentes JY, Kirkpatrik ND, Nagano S, et al. Cancer cell-as- sociated MT1-MMP promotes blood vessel invasion and dis- tant metastasis in triple-negativemammary tumors. Cancer Res, 2011,71(13) :4527-4538.
  • 5Wan X, Mendoza A, Khanna C, et al. Rapamyein inhibits ezrin-mediated metastasis behavior in a murine model of os- teosarcoma. Cancer Res, 2005,65(6) ..2406-2411.
  • 6Jayo A,Parson M. Fasin: a key regulator of cytoskeletal dy- namics. Int J Biochem Cell Biol, 2010,33(2):422-429.
  • 7Elosi G, Pastorino U, Pasini F, et a[. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer, 2003,88 (4) : 537-547.
  • 8牟燕,孙瑛伟,蔡宏伟.曲马多对体外培养人肝癌细胞株HepG2的影响[J].肿瘤药学,2011,1(3):185-188. 被引量:1
  • 9梁桦,古妙宁,杨承祥,文先杰,周桥灵.七氟醚对顺铂抑制人肺腺癌细胞株A549侵袭和迁移能力的影响[J].中华麻醉学杂志,2012,32(2):158-160. 被引量:5
  • 10梁桦,廖美娟,赖晓红,黄翔,杨承祥.七氟醚对顺铂和γ射线抑制人肺腺癌A549细胞生长作用的影响[J].中华麻醉学杂志,2013,33(4):455-458. 被引量:3

二级参考文献26

  • 1丁汉琳,张咸伟,张传汉.芬太尼影响MCF7细胞凋亡的实验研究[J].实用医学杂志,2004,20(12):1351-1353. 被引量:16
  • 2张咸伟,丁汉琳,张传汉,田玉科.芬太尼对MCF-7细胞增殖和细胞周期影响研究[J].中国医师杂志,2005,7(1):23-25. 被引量:13
  • 3周桂霞,曾逖闻,王连元,马林.非小细胞肺癌术中放疗的前瞻性研究[J].中华放射肿瘤学杂志,2006,15(1):15-18. 被引量:8
  • 4Zhang Q, Tey J, Peng L, et al. Adjuvant chemoradiotherapy with or without intraoperative radiotherapy for the treatment of resectable lo- cally advanced gastric adenocarcinoma. Radiother Oncol, 2012, 102 ( 1 ) :51-55.
  • 5De Lorenzi F, Lohsiriwat V, Barbieri B, et al. Immediate breast re- construction with prostheses after conservative treatment plus intraop- erative radiotherapy. Long term esthetic and oncological outcomes. Breast, 2012, 21(3):374-379.
  • 6Geiger S, Schlemmer M, Heinemann V, et al. Adjuvant cisplatin- based chemotherapy for resected NSCLC: one size fits all? Antieancer Drugs, 2010, 21(9):799-804.
  • 7Besse B, Le Chevalier T. Developments in the treatment of early NSCLC: when to use chemotherapy. Ann Oncol, 2012, 23 Suppl 10 : x52-x59.
  • 8Kang KM, Jeong BK, Ha IB, et al. Concurrent chemoradiotherapy for elderly patients with stage m non-small cell lung cancer. RadiatOncol J, 2012, 30(3):140-145.
  • 9Dean E J, Ward T, Pinilla C, et al. A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC. Br J Cancer, 2010, 102(1) :97-103.
  • 10Liu Y, Wu X, Sun Y, et al. Silencing of X-linked inhibitor of apop- tosis decreases resistance to cisplatin and paclitaxel but not gemeit- abine in non-small cell lung cancer. J Int Med Res, 2011, 39(5) : 1682-1692.

共引文献11

同被引文献52

  • 1Qi-Hang Du,Yan-Bing Xu,Meng-Yuan Zhang,Peng Yun,Chang-Yao He.Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of nuclear factor-κ B activity[J].World Journal of Gastroenterology,2013,19(33):5485-5492. 被引量:10
  • 2朱宪军,张学德.八宝丹防治肿瘤化疗毒副作用的临床观察[J].中国民间疗法,2006,14(5):45-46. 被引量:8
  • 3吴镜湘,陈明,赵丽丽,梁昌毅,徐美英.胸科手术后舒芬太尼静脉镇痛的剂量探讨[J].临床麻醉学杂志,2007,23(1):22-23. 被引量:50
  • 4Jeleazcov C, Saari TI, Ihmsen H, et al. Population pharmaco- kinetic modeling o{ hydromorphone in cardiac surgery patients during postoperative pain therapy. Anesthesiology, 2014,120 (2) :378-391.
  • 5Scott LJ, Perry CM. Tramadol: A review of its use in periop: erative pain: Drugs, 2000, 60(1) :139-176.
  • 6Lennon FE, Moss J, Singleton PA. The p. opioid receptor in cancer progression= is there a direct effect.'? Anesthesiology, 2012,116(4) =940-945.
  • 7Lennon FE, Mirzapoiazova T, Mambetsariev B, el al.Over- expression of the t,-opioid receptor in human non-small cell lung cancer promotes Akt and roTOR activation, tumor growth, and metastasis. Anesthesiology, 2012, 116 ( 4 ): 857-867.
  • 8Moss J, Paterson C. Methylnahrexone (Relistor") does not impact opioid-mediated analgesia at therapeutic doses. Pain, 2014,155 (12) : 2722.
  • 9Mathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg, 2011,112(3) :558-567.
  • 10Ouadd-Ahidouch H, Le Bourhis X, Roudbarki M, et al. Chan- ges in the K+current-density of MCF-7 cells during progres- sion through the cell cycle: possible involvement of a h-ether. a-gogo K+channel. Receptors Channels, 2001,7 (5) : 345-356.

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部